Clin2
NCT02129751Possibly a fitNot yet recruiting

Bupropion for depression in children and teens

Major Depressive Disorder

Part of Mental health clinical trials.

This study tests a medication called bupropion (an antidepressant) in children and teens with depression. It aims to see if it is safe and effective for this age group.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
246 people
Ages
7 years to 17 years
Study type
Interventional

Who can take part

  • Be between 7 and 17 years old
  • Have a diagnosis of major depressive disorder (depression)
  • Be able to swallow pills
  • Not have a seizure disorder or history of seizures or head injury
  • Not have a history of attempted suicide

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06223880Recruiting· Phase 4
AXS-05 vs Bupropion to prevent depression relapse

This study tests whether a new drug called AXS-05 can prevent depression from coming back, compared to an older drug called bupropion. If you have major depression and are at risk of relapse, this trial may help you stay well.

Bellflower, California
NCT07772531Not yet recruiting· Phase 2
Study of a new drug for major depressive disorder

This study tests a new medication called BMS-986511 for adults with major depressive disorder. It aims to see if the drug can help relieve depression symptoms more effectively than a placebo.

Phoenix, Arizona
NCT06054321Recruiting
Depression medication study for adults 19 to 65

This study tests a new way of choosing antidepressants for people with major depression. It's designed for adults aged 19–65 who have moderate to severe depression and are either starting a new antidepressant or have been off psychiatric meds for at least a month.

Gwangju
NCT07204314Recruiting· Phase 3
Study of vortioxetine for teens with depression in Japan

This trial tests whether vortioxetine helps reduce symptoms of major depression in Japanese teenagers aged 12-17. It compares the study drug to a placebo to see if it is safe and effective.

Nagoya, Aichi-ken
NCT07523048Recruiting· Phase 2
Dextromethorphan-Bupropion for Moderate-to-Severe Depression

This study tests a combination medication (dextromethorphan plus bupropion) to see how it affects brain activity in people with moderate-to-severe depression. Researchers use brain imaging (fMRI) to understand how the drug works and whether it may help relieve depression symptoms.

Toronto, Ontario
NCT06958692Recruiting· Phase 3
Testing a new antidepressant combination for depression

This study tests a new combination of two medications (dextromethorphan and bupropion) as a treatment for major depressive disorder. It may be an option if you have not already tried many antidepressants that didn't work.

Beijing, Beijing Municipality

Hear when a new Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.